open access

Vol 69, No 8 (2011)
Nasze forum - kardiolodzy i kardiochirurdzy razem
Published online: 2011-08-17
Submitted: 2012-12-28
Get Citation

Thrombo-embolic pulmonary hypertension — do not spoil a chance for effective surgery!

Marcin Kurzyna, Adam Torbicki, Lech Poloński, Ilona Skoczylas, Roman Przybylski, Maria Wieteska, Wojciech Dyk, Andrzej Biederman, Marian Zembala
Kardiol Pol 2011;69(8):875-878.

open access

Vol 69, No 8 (2011)
Nasze forum - kardiolodzy i kardiochirurdzy razem
Published online: 2011-08-17
Submitted: 2012-12-28

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) can be defined as pulmonary hypertension with persistent pulmonary perfusion defects causes by unresolved thrombi. All symptomatic CTEPH patients with documented pulmonary vascular resistance > 300 dyn*sec*cm–5 and proximal lesions should be considered for surgical treatment — pulmonary endarterectomy. The role of pharmacological treatment remains controversial and should be restricted to inoperable cases and persistent pulmonary hypertension after pulmonary endarterectomy. Every year about 30 procedures is performed in two specialised centers in Poland with 1 year mortality at 8–9 %. Number of procedures done gives the frequency of pulmonary endarterectomy at 0.7/million of population/year. Current data from UK indicate the actual ratio of surgical treatment of CTPH at 2/million/year. The article discusses reasons for CTEPH is underdiagnosed and why rate of surgical therapy in Poland is too low.
Kardiol Pol 2011; 69, 8: 875–878

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) can be defined as pulmonary hypertension with persistent pulmonary perfusion defects causes by unresolved thrombi. All symptomatic CTEPH patients with documented pulmonary vascular resistance > 300 dyn*sec*cm–5 and proximal lesions should be considered for surgical treatment — pulmonary endarterectomy. The role of pharmacological treatment remains controversial and should be restricted to inoperable cases and persistent pulmonary hypertension after pulmonary endarterectomy. Every year about 30 procedures is performed in two specialised centers in Poland with 1 year mortality at 8–9 %. Number of procedures done gives the frequency of pulmonary endarterectomy at 0.7/million of population/year. Current data from UK indicate the actual ratio of surgical treatment of CTPH at 2/million/year. The article discusses reasons for CTEPH is underdiagnosed and why rate of surgical therapy in Poland is too low.
Kardiol Pol 2011; 69, 8: 875–878
Get Citation

Keywords

chronic thromboembolic pulmonary hypertension; pulmonary endarterectomy; surgery; treatment; outcome

About this article
Title

Thrombo-embolic pulmonary hypertension — do not spoil a chance for effective surgery!

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 69, No 8 (2011)

Pages

875-878

Published online

2011-08-17

Bibliographic record

Kardiol Pol 2011;69(8):875-878.

Keywords

chronic thromboembolic pulmonary hypertension
pulmonary endarterectomy
surgery
treatment
outcome

Authors

Marcin Kurzyna
Adam Torbicki
Lech Poloński
Ilona Skoczylas
Roman Przybylski
Maria Wieteska
Wojciech Dyk
Andrzej Biederman
Marian Zembala

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl